Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
368
datasets available to search
ShareScore release 0.9.0
Dataset results
368 results for “ranibizumab”
Use of Ranibizumab With Mitomycin C During Trabeculectomy
ClinicalTrials.gov study NCT00661583. IPD Sharing: NO. Countries: 1. Publications: 1.
RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity
ClinicalTrials.gov study NCT02375971. IPD Sharing: UNDECIDED. Countries: 26. Publications: 2.
Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy
ClinicalTrials.gov study NCT00837330. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT00445003. IPD Sharing: Not stated. Countries: 1. Publications: 14.
Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy
ClinicalTrials.gov study NCT01325181. IPD Sharing: Not stated. Countries: 1. Publications: 2.
A Study to Compare SB11 (Proposed Ranibizumab Biosimilar) to Lucentis in Subjects With Neovascular Age-related Macular Degeneration (AMD)
ClinicalTrials.gov study NCT03150589. IPD Sharing: NO. Countries: 9. Publications: 2.
Efficacy and Safety of Ranibizumab With or Without Laser in Comparison to Laser in Branch Retinal Vein Occlusion
ClinicalTrials.gov study NCT01599650. IPD Sharing: Not stated. Countries: 17. Publications: 3.
Efficacy and Safety of Ranibizumab in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia
ClinicalTrials.gov study NCT01217944. IPD Sharing: Not stated. Countries: 20. Publications: 2.
A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.
ClinicalTrials.gov study NCT02034006. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Treat & Extend Treatment With 0.5mg Ranibizumab vs Monthly Treatment With 0.5mg Ranibizumab
ClinicalTrials.gov study NCT01748292. IPD Sharing: NO. Countries: 1. Publications: 15.
A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab
ClinicalTrials.gov study NCT02859441. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study in Patients With Neovascular Age Related Macular Degeneration or Macular Edema Secondary To Retinal Vein Occlusion to Evaluate Usability of the Ranibizumab (Lucentis®) Prefilled Syringe (PFS)
ClinicalTrials.gov study NCT02698566. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
ClinicalTrials.gov study NCT01489189. IPD Sharing: Not stated. Countries: 1. Publications: 17.
Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept
ClinicalTrials.gov study NCT01617148. IPD Sharing: NO. Countries: 1. Publications: 2.
Efficacy and Safety of Two Treatment Regimens of 0.5 mg Ranibizumab Intravitreal Injections Guided by Functional and/or Anatomical Criteria, in Patients With Neovascular Age-related Macular Degenerati
ClinicalTrials.gov study NCT01780935. IPD Sharing: Not stated. Countries: 24. Publications: 1.
A Safety and Efficacy Trial of a Treat and Extend Protocol Using Ranibizumab With and Without Laser Photocoagulation for Diabetic Macular Edema
ClinicalTrials.gov study NCT01934556. IPD Sharing: Not stated. Countries: 1. Publications: 3.
Study of 2.0 mg Ranibizumab in Subjects With Ischemic Central Retinal Vein Occlusion (RAVE2)
ClinicalTrials.gov study NCT01225146. IPD Sharing: NO. Countries: 1. Publications: 1.
Ranibizumab Intravitreal Injections Versus Sham Control in Patients With Branch Retinal Vein Occlusion (BRVO)
ClinicalTrials.gov study NCT01976338. IPD Sharing: Not stated. Countries: 6. Publications: 1.
Safety and Efficacy of Switching From Aflibercept to Ranibizumab in Patients With nAMD
ClinicalTrials.gov study NCT02161575. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Ranibizumab in Hemorrhagic Choroidal Neovascularization Trial
ClinicalTrials.gov study NCT00363168. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.